Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
PROV vs BSVN vs HOMB vs FFIN
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
PROV vs BSVN vs HOMB vs FFIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $109M | $446M | $5.58B | $4.83B |
| Revenue (TTM) | $60M | $137M | $1.37B | $826M |
| Net Income (TTM) | $7M | $43M | $475M | $254M |
| Gross Margin | 67.8% | 69.7% | 77.3% | 71.8% |
| Operating Margin | 16.2% | 41.4% | 43.8% | 37.5% |
| Forward P/E | 15.4x | 10.5x | 11.5x | 16.5x |
| Total Debt | $213M | $0.00 | $935M | $22M |
| Cash & Equiv. | $53M | $245M | $667M | $1.08B |
PROV vs BSVN vs HOMB vs FFIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Provident Financial… (PROV) | 100 | 127.6 | +27.6% |
| Bank7 Corp. (BSVN) | 100 | 428.0 | +328.0% |
| Home Bancshares, In… (HOMB) | 100 | 183.7 | +83.7% |
| First Financial Ban… (FFIN) | 100 | 116.5 | +16.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PROV vs BSVN vs HOMB vs FFIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PROV is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 0 yrs, beta 0.21, yield 3.3%
- Lower volatility, beta 0.21, current ratio 0.06x
- Beta 0.21, yield 3.3%, current ratio 0.06x
- Beta 0.21 vs FFIN's 0.78
BSVN carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 169.2% 10Y total return vs HOMB's 57.7%
- PEG 0.61 vs FFIN's 3.67
- NIM 4.5% vs PROV's 2.8%
- Lower P/E (10.5x vs 16.5x), PEG 0.61 vs 3.67
HOMB lags the leaders in this set but could rank higher in a more targeted comparison.
FFIN is the clearest fit if your priority is growth exposure.
- Rev growth 11.7%, EPS growth 13.5%
- 11.7% NII/revenue growth vs HOMB's -5.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.7% NII/revenue growth vs HOMB's -5.3% | |
| Value | Lower P/E (10.5x vs 16.5x), PEG 0.61 vs 3.67 | |
| Quality / Margins | Efficiency ratio 0.3% vs PROV's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.21 vs FFIN's 0.78 | |
| Dividends | 3.3% yield, vs HOMB's 2.8% | |
| Momentum (1Y) | +20.3% vs FFIN's -5.5% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs PROV's 0.5% |
PROV vs BSVN vs HOMB vs FFIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PROV vs BSVN vs HOMB vs FFIN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BSVN leads in 2 of 6 categories
HOMB leads 1 • FFIN leads 1 • PROV leads 1 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HOMB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
HOMB is the larger business by revenue, generating $1.4B annually — 22.9x PROV's $60M. HOMB is the more profitable business, keeping 34.6% of every revenue dollar as net income compared to PROV's 11.0%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $60M | $137M | $1.4B | $826M |
| EBITDAEarnings before interest/tax | $12M | $58M | $618M | $320M |
| Net IncomeAfter-tax profit | $7M | $43M | $475M | $254M |
| Free Cash FlowCash after capex | $9M | $36M | $311M | $283M |
| Gross MarginGross profit ÷ Revenue | +67.8% | +69.7% | +77.3% | +71.8% |
| Operating MarginEBIT ÷ Revenue | +16.2% | +41.4% | +43.8% | +37.5% |
| Net MarginNet income ÷ Revenue | +11.0% | +31.4% | +34.6% | +30.7% |
| FCF MarginFCF ÷ Revenue | +15.3% | +26.4% | +22.6% | +34.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +69.2% | -3.4% | +26.0% | -7.7% |
Valuation Metrics
BSVN leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 10.3x trailing earnings, BSVN trades at a 46% valuation discount to FFIN's 19.0x P/E. Adjusting for growth (PEG ratio), BSVN offers better value at 0.61x vs FFIN's 4.22x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $109M | $446M | $5.6B | $4.8B |
| Enterprise ValueMkt cap + debt − cash | $269M | $202M | $5.9B | $3.8B |
| Trailing P/EPrice ÷ TTM EPS | 18.40x | 10.33x | 11.72x | 19.01x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.41x | 10.46x | 11.47x | 16.54x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.61x | 0.89x | 4.22x |
| EV / EBITDAEnterprise value multiple | 21.77x | 3.48x | 9.47x | 11.79x |
| Price / SalesMarket cap ÷ Revenue | 1.81x | 3.25x | 4.06x | 5.85x |
| Price / BookPrice ÷ Book value/share | 0.90x | 1.77x | 1.30x | 2.52x |
| Price / FCFMarket cap ÷ FCF | 13.38x | 10.78x | 11.58x | 15.72x |
Profitability & Efficiency
FFIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BSVN delivers a 18.2% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $5 for PROV. FFIN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to PROV's 1.66x. On the Piotroski fundamental quality scale (0–9), FFIN scores 8/9 vs BSVN's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +18.2% | +11.4% | +14.2% |
| ROA (TTM)Return on assets | +0.5% | +2.3% | +2.1% | +1.7% |
| ROICReturn on invested capital | +1.9% | +18.3% | +8.7% | +12.4% |
| ROCEReturn on capital employed | +2.4% | +5.2% | +11.5% | +16.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 8 |
| Debt / EquityFinancial leverage | 1.66x | — | 0.22x | 0.01x |
| Net DebtTotal debt minus cash | $160M | -$245M | $268M | -$1.1B |
| Cash & Equiv.Liquid assets | $53M | $245M | $667M | $1.1B |
| Total DebtShort + long-term debt | $213M | $0 | $935M | $22M |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 1.39x | 1.47x | 1.54x |
Total Returns (Dividends Reinvested)
BSVN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BSVN five years ago would be worth $28,907 today (with dividends reinvested), compared to $7,409 for FFIN. Over the past 12 months, BSVN leads with a +20.3% total return vs FFIN's -5.5%. The 3-year compound annual growth rate (CAGR) favors BSVN at 25.4% vs FFIN's 7.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +8.8% | +13.0% | +2.7% | +13.5% |
| 1-Year ReturnPast 12 months | +14.5% | +20.3% | +3.0% | -5.5% |
| 3-Year ReturnCumulative with dividends | +50.9% | +97.2% | +31.2% | +24.3% |
| 5-Year ReturnCumulative with dividends | +18.2% | +189.1% | +22.1% | -25.9% |
| 10-Year ReturnCumulative with dividends | +25.8% | +169.2% | +57.7% | +136.4% |
| CAGR (3Y)Annualised 3-year return | +14.7% | +25.4% | +9.5% | +7.5% |
Risk & Volatility
PROV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PROV is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than FFIN's 0.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PROV currently trades 98.2% from its 52-week high vs FFIN's 86.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.64x | 0.66x | 0.78x |
| 52-Week HighHighest price in past year | $17.42 | $50.10 | $30.83 | $38.74 |
| 52-Week LowLowest price in past year | $14.95 | $37.56 | $25.50 | $28.11 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +92.8% | +91.6% | +86.9% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 62.6 | 63.7 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 8K | 11K | 1.4M | 683K |
Analyst Outlook
Evenly matched — PROV and HOMB and FFIN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PROV as "Hold", BSVN as "Buy", HOMB as "Hold", FFIN as "Hold". Consensus price targets imply 22.6% upside for BSVN (target: $57) vs -6.5% for PROV (target: $16). For income investors, PROV offers the higher dividend yield at 3.26% vs BSVN's 2.10%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $16.00 | $57.00 | $31.50 | $39.25 |
| # AnalystsCovering analysts | 10 | 3 | 19 | 15 |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +2.1% | +2.8% | +2.2% |
| Dividend StreakConsecutive years of raises | 0 | 7 | 15 | 15 |
| Dividend / ShareAnnual DPS | $0.56 | $0.98 | $0.80 | $0.74 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | +0.3% | +1.5% | 0.0% |
BSVN leads in 2 of 6 categories (Valuation Metrics, Total Returns). HOMB leads in 1 (Income & Cash Flow). 1 tied.
PROV vs BSVN vs HOMB vs FFIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PROV or BSVN or HOMB or FFIN a better buy right now?
For growth investors, First Financial Bankshares, Inc.
(FFIN) is the stronger pick with 11. 7% revenue growth year-over-year, versus -5. 3% for Home Bancshares, Inc. (HOMB). Bank7 Corp. (BSVN) offers the better valuation at 10. 3x trailing P/E (10. 5x forward), making it the more compelling value choice. Analysts rate Bank7 Corp. (BSVN) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PROV or BSVN or HOMB or FFIN?
On trailing P/E, Bank7 Corp.
(BSVN) is the cheapest at 10. 3x versus First Financial Bankshares, Inc. at 19. 0x. On forward P/E, Bank7 Corp. is actually cheaper at 10. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank7 Corp. wins at 0. 61x versus First Financial Bankshares, Inc. 's 3. 67x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PROV or BSVN or HOMB or FFIN?
Over the past 5 years, Bank7 Corp.
(BSVN) delivered a total return of +189. 1%, compared to -25. 9% for First Financial Bankshares, Inc. (FFIN). Over 10 years, the gap is even starker: BSVN returned +169. 2% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PROV or BSVN or HOMB or FFIN?
By beta (market sensitivity over 5 years), Provident Financial Holdings, Inc.
(PROV) is the lower-risk stock at 0. 21β versus First Financial Bankshares, Inc. 's 0. 78β — meaning FFIN is approximately 280% more volatile than PROV relative to the S&P 500. On balance sheet safety, First Financial Bankshares, Inc. (FFIN) carries a lower debt/equity ratio of 1% versus 166% for Provident Financial Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PROV or BSVN or HOMB or FFIN?
By revenue growth (latest reported year), First Financial Bankshares, Inc.
(FFIN) is pulling ahead at 11. 7% versus -5. 3% for Home Bancshares, Inc. (HOMB). On earnings-per-share growth, the picture is similar: Home Bancshares, Inc. grew EPS 19. 9% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PROV or BSVN or HOMB or FFIN?
Home Bancshares, Inc.
(HOMB) is the more profitable company, earning 34. 6% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 34. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOMB leads at 43. 8% versus 14. 8% for PROV. At the gross margin level — before operating expenses — HOMB leads at 77. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PROV or BSVN or HOMB or FFIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bank7 Corp. (BSVN) is the more undervalued stock at a PEG of 0. 61x versus First Financial Bankshares, Inc. 's 3. 67x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank7 Corp. (BSVN) trades at 10. 5x forward P/E versus 16. 5x for First Financial Bankshares, Inc. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BSVN: 22. 6% to $57. 00.
08Which pays a better dividend — PROV or BSVN or HOMB or FFIN?
All stocks in this comparison pay dividends.
Provident Financial Holdings, Inc. (PROV) offers the highest yield at 3. 3%, versus 2. 1% for Bank7 Corp. (BSVN).
09Is PROV or BSVN or HOMB or FFIN better for a retirement portfolio?
For long-horizon retirement investors, Provident Financial Holdings, Inc.
(PROV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 3% yield). Both have compounded well over 10 years (PROV: +25. 8%, FFIN: +136. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PROV and BSVN and HOMB and FFIN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PROV is a small-cap income-oriented stock; BSVN is a small-cap deep-value stock; HOMB is a small-cap deep-value stock; FFIN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.